Drooid Logo
Back to story perspectives

Full Breakdown

Black Women Face Menopause Challenges Amid Growing Telehealth Initiatives

5/5/2026, 12:49:10 AM

Disparities in Perimenopause and Menopause for Black Women

Black women enter perimenopause earlier, endure it longer, and report more severe symptoms than White peers. Only 1 % of Black women use hormone replacement therapy (HRT) versus 5 % of all women, despite untreated hot flashes raising stroke and heart-attack risk.

Historical and Systemic Context

Long-standing health-care inequities, discrimination, and economic gaps have lowered Black women’s life expectancy to 77 years, versus 81 for White women. These systemic factors shape baseline health at menopause onset and magnify adverse outcomes.

Leaders Driving Change

Kudzai Dombo, director of advocacy and outreach for Alloy, leads community education. Sharon Malone, obstetrician-gynecologist and Alloy’s chief medical adviser, guides clinical outreach. Vickie Franklin, nurse and health-program coordinator at First AME Church in Los Angeles, hosts support sessions. Melani Sanders promotes the “We do not care” movement to normalize menopause discussion.

Data on Onset, Treatment Gaps, and Health Outcomes

Black women reach menopause on average two years earlier than White women (Study of Women’s Health Across the Nation). HRT use is 5 % of all women but only 1 % among Black women (JAMA). A 2021 study links unmanaged hot flashes to higher stroke and heart-attack incidence. Breast-cancer mortality is higher for Black women despite similar incidence rates.

Community Outreach and Telehealth Solutions

Alloy pairs Black women with telehealth providers and virtual support groups. At First AME Church, gatherings discuss vaginal estrogen, testosterone, and lifestyle coping. Sessions invite partners to foster shared understanding and reduce marital strain.

Official Statements from Health Professionals and Agencies

Alloy’s leadership stresses clinician education to avoid misdiagnosing perimenopausal symptoms as stress or weight issues. Malone notes the FDA removed a 2002 warning label from estrogen products in fall 2025, eliminating outdated safety concerns. Dombo says telehealth can fill gaps left by care.

Criticism of Clinical Practices

Patients report providers often dismiss symptoms as “just stress” or attribute them to body weight, causing delayed treatment. The shortage of trusted Black physicians deepens diagnostic uncertainty.

Why These Disparities Matter

Unaddressed menopausal symptoms increase cardiovascular events, lower quality of life, and raise premature mortality. Closing the treatment gap could boost life expectancy and bring Black women’s health outcomes closer to those of White women.

Conflicting Reports & Gaps

Research provides limited quantitative data on perimenopausal symptom prevalence among Black women, and few longitudinal studies track long-term cardiovascular outcomes after menopause.

Verbatim Quotes

  • “Black women have been left behind,” — Kudzai Dombo, Advocacy Director, Alloy
  • “'Oh it’s just stress,' or 'oh, it’s just your weight.'” — Sharon Malone, Ob-Gynecologist, Alloy
  • “And that just isn’t true anymore. Black women now are saying that they aren’t going to let outdated information affect their overall health and wellbeing.” — Sharon Malone, Ob-Gynecologist, Alloy
  • “We do not care.” — Melani Sanders, Perimenopause Advocate

What’s Next

Alloy will extend telehealth coverage to additional states in 2026. First AME Church will host a follow-up series titled “Still hot, still holy.” Researchers plan a multi-site study on cardiovascular risk among Black menopausal women.